Publication | Closed Access

Fluorescent peptide nanoparticles to detect amyloid-beta aggregation in cerebrospinal fluid and serum for Alzheimer’s disease diagnosis and progression monitoring

NanoparticlesEngineeringNeurochemical BiomarkersPeptide ScienceProtein NanoparticlesAlzheimer's DiseaseProtein MisfoldingNeurologyBrain PathologyMolecular ImagingBiophysicsAmyloid-beta AggregationNanobiotechnologyNeurodegenerative DiseasesProgression MonitoringBiomedical DiagnosticsBiomarkersNeuroscienceMedicineFluorescent Peptide Nanoparticles